Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia
|ClinicalTrials.gov Identifier: NCT03734822|
Recruitment Status : Completed
First Posted : November 8, 2018
Results First Posted : March 14, 2019
Last Update Posted : March 14, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cystic Fibrosis||Other: End tidal CO2 (EtCO2) Device: Transcutaneous CO2 (TCO2) Diagnostic Test: Capillary CO2 (CapCO2) Diagnostic Test: Arterial blood gas (ABG)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia|
|Actual Study Start Date :||March 10, 2016|
|Actual Primary Completion Date :||December 20, 2017|
|Actual Study Completion Date :||December 20, 2017|
Cystic fibrosis patients undergoing general anesthesia.
Other: End tidal CO2 (EtCO2)
End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia.
Device: Transcutaneous CO2 (TCO2)
Continuous and noninvasive real-time monitoring of transcutaneous CO2.
Other Name: The SenTec Digital Monitoring System (SDMS)
Diagnostic Test: Capillary CO2 (CapCO2)
Capillary CO2 collected by finger stick and run on the i-STAT handheld blood analyzer.
Diagnostic Test: Arterial blood gas (ABG)
Arterial blood gas collected from the radial artery and run on the i-STAT handheld blood analyzer.
- Accuracy of CO2 Levels [ Time Frame: Immediately following induction of anesthesia ]Looking at the accuracy of CO2 levels assessed via end tidal CO2 (ETCO2), capillary CO2 (Cap-CO2), and transcutaneous CO2 (TCCO2) compared to arterial blood gas (ABG) which is the gold standard.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03734822
|United States, Ohio|
|Nationwide Children's Hospital|
|Columbus, Ohio, United States, 43205|